CHDI Foundation

File:Chdi-logo.png

Non-profit biomedical research organization

CHDI Foundation
[[File:		alt=]]
Formation
Type	Non-profit organization
Headquarters
Membership
Language
Leader title
Leader name
Website

The CHDI Foundation is a non-profit organization focused on biomedical research with the primary goal of discovering and developing therapies for Huntington's disease. The foundation collaborates with a wide range of academic and industrial researchers to accelerate the development of treatments.

History

The CHDI Foundation was established to address the urgent need for effective treatments for Huntington's disease, a hereditary neurodegenerative disorder. The foundation's name, CHDI, stands for "Cure Huntington's Disease Initiative," reflecting its mission.

Mission

The mission of the CHDI Foundation is to support and conduct research that will lead to the discovery and development of drugs that slow the progression of Huntington's disease or provide symptomatic relief. The foundation aims to bridge the gap between basic research and clinical application.

Research Programs

CHDI Foundation funds and collaborates on a variety of research programs, including:

• **Genetic Research**: Investigating the genetic underpinnings of Huntington's disease to identify potential therapeutic targets.
• **Drug Discovery**: Developing small molecules and other therapeutic agents that can modify the disease process.
• **Biomarker Development**: Identifying biomarkers that can be used to track disease progression and response to treatment.
• **Clinical Trials**: Supporting clinical trials to test the efficacy and safety of potential therapies.

Collaborations

The CHDI Foundation collaborates with numerous academic institutions, biotechnology companies, and pharmaceutical companies. These collaborations are designed to leverage the expertise and resources of various partners to accelerate the development of effective treatments.

Impact

The foundation has significantly contributed to the understanding of Huntington's disease and has been instrumental in advancing several potential therapies into clinical trials. Its collaborative approach has fostered a more integrated and efficient research environment.

See also

• Huntington's disease
• Neurodegenerative disease
• Biomedical research
• Non-profit organization

References

   This article is a medical stub. You can help WikiMD by expanding it!